There are no direct FOXA1 inhibitors; however, there are many indirect mechanisms of FOXA1 inhibition being explored in other cancers [113], but given the conflicting reports on its expression in NEPC, it is suggested that this should not be targetable in this disease. The gene discussed is FOXA1; the disease is cancer.